Global Next Generation Cancer Diagnostic Devices Market Professional Survey Report 2018


Report ID : RC-1855 Category : Consumer And Goods Published Date : 18-Oct
Publisher : QYResearch Pages : 114 Format : PDF
This report studies Next Generation Cancer Diagnostic Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2023.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Roche Holding Ltd.(Switzerland)
    Abbott Laboratories(US)
    Siemens Healthcare(Germany)
    Agilent Technologies Inc(Germany)
    Illumina Inc.(US)
    Becton Dickinson and Co.(US)
    QIAGEN N.V.(Germany)
    Affymetrix Inc.(US)
    Johnson & Johnson(US)
    Thermo Fisher Scientific Inc.(US)
    GE Healthcare(England)
    Life Technologies Corp.(US)
    Luminex Corp.(US)
    Cepheid Inc.(US)
    Allegro Diagnostics Corp.(Brazil)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Next Generation Sequencing
    qPCR & Multiplexing
    Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
    Protein Microarrays
    DNA Microarrays

By Application, the market can be split into
    Biomarker Development
    CTC Analysis
    Proteomic Analysis
    Epigenetic Analysis
    Genetic Analysis

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.
Global Next Generation Cancer Diagnostic Devices Market Professional Survey Report 2018
1 Industry Overview of Next Generation Cancer Diagnostic Devices
    1.1 Definition and Specifications of Next Generation Cancer Diagnostic Devices
        1.1.1 Definition of Next Generation Cancer Diagnostic Devices
        1.1.2 Specifications of Next Generation Cancer Diagnostic Devices
    1.2 Classification of Next Generation Cancer Diagnostic Devices
        1.2.1 Next Generation Sequencing
        1.2.2 qPCR & Multiplexing
        1.2.3 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
        1.2.4 Protein Microarrays
        1.2.5 DNA Microarrays
    1.3 Applications of Next Generation Cancer Diagnostic Devices
        1.3.1 Biomarker Development
        1.3.2 CTC Analysis
        1.3.3 Proteomic Analysis
        1.3.4 Epigenetic Analysis
        1.3.5 Genetic Analysis
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostic Devices
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Next Generation Cancer Diagnostic Devices
    2.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
    2.4 Industry Chain Structure of Next Generation Cancer Diagnostic Devices

3 Technical Data and Manufacturing Plants Analysis of Next Generation Cancer Diagnostic Devices
    3.1 Capacity and Commercial Production Date of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016

4 Global Next Generation Cancer Diagnostic Devices Overall Market Overview
    4.1 2012-2018E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2018E Global Next Generation Cancer Diagnostic Devices Capacity and Growth Rate Analysis
        4.2.2 2016 Next Generation Cancer Diagnostic Devices Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2018E Global Next Generation Cancer Diagnostic Devices Sales and Growth Rate Analysis
        4.3.2 2016 Next Generation Cancer Diagnostic Devices Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2018E Global Next Generation Cancer Diagnostic Devices Sales Price
        4.4.2 2016 Next Generation Cancer Diagnostic Devices Sales Price Analysis (Company Segment)

5 Next Generation Cancer Diagnostic Devices Regional Market Analysis
    5.1 North America Next Generation Cancer Diagnostic Devices Market Analysis
        5.1.1 North America Next Generation Cancer Diagnostic Devices Market Overview
        5.1.2 North America 2012-2018E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2018E Next Generation Cancer Diagnostic Devices Sales Price Analysis
        5.1.4 North America 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
    5.2 China Next Generation Cancer Diagnostic Devices Market Analysis
        5.2.1 China Next Generation Cancer Diagnostic Devices Market Overview
        5.2.2 China 2012-2018E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2018E Next Generation Cancer Diagnostic Devices Sales Price Analysis
        5.2.4 China 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
    5.3 Europe Next Generation Cancer Diagnostic Devices Market Analysis
        5.3.1 Europe Next Generation Cancer Diagnostic Devices Market Overview
        5.3.2 Europe 2012-2018E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2018E Next Generation Cancer Diagnostic Devices Sales Price Analysis
        5.3.4 Europe 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
    5.4 Southeast Asia Next Generation Cancer Diagnostic Devices Market Analysis
        5.4.1 Southeast Asia Next Generation Cancer Diagnostic Devices Market Overview
        5.4.2 Southeast Asia 2012-2018E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2018E Next Generation Cancer Diagnostic Devices Sales Price Analysis
        5.4.4 Southeast Asia 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
    5.5 Japan Next Generation Cancer Diagnostic Devices Market Analysis
        5.5.1 Japan Next Generation Cancer Diagnostic Devices Market Overview
        5.5.2 Japan 2012-2018E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2018E Next Generation Cancer Diagnostic Devices Sales Price Analysis
        5.5.4 Japan 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis
    5.6 India Next Generation Cancer Diagnostic Devices Market Analysis
        5.6.1 India Next Generation Cancer Diagnostic Devices Market Overview
        5.6.2 India 2012-2018E Next Generation Cancer Diagnostic Devices Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2018E Next Generation Cancer Diagnostic Devices Sales Price Analysis
        5.6.4 India 2016 Next Generation Cancer Diagnostic Devices Market Share Analysis

6 Global 2012-2018E Next Generation Cancer Diagnostic Devices Segment Market Analysis (by Type)
    6.1 Global 2012-2018E Next Generation Cancer Diagnostic Devices Sales by Type
    6.2 Different Types of Next Generation Cancer Diagnostic Devices Product Interview Price Analysis
    6.3 Different Types of Next Generation Cancer Diagnostic Devices Product Driving Factors Analysis
        6.3.1 Next Generation Sequencing of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
        6.3.2 qPCR & Multiplexing of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
        6.3.3 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
        6.3.4 Protein Microarrays of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
        6.3.5 DNA Microarrays of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis

7 Global 2012-2018E Next Generation Cancer Diagnostic Devices Segment Market Analysis (by Application)
    7.1 Global 2012-2018E Next Generation Cancer Diagnostic Devices Consumption by Application
    7.2 Different Application of Next Generation Cancer Diagnostic Devices Product Interview Price Analysis
    7.3 Different Application of Next Generation Cancer Diagnostic Devices Product Driving Factors Analysis
        7.3.1 Biomarker Development of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
        7.3.2 CTC Analysis of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
        7.3.3 Proteomic Analysis of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
        7.3.4 Epigenetic Analysis of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis
        7.3.5 Genetic Analysis of Next Generation Cancer Diagnostic Devices Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Next Generation Cancer Diagnostic Devices
    8.1 Roche Holding Ltd.(Switzerland)
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Roche Holding Ltd.(Switzerland) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Roche Holding Ltd.(Switzerland) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.2 Abbott Laboratories(US)
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Abbott Laboratories(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Abbott Laboratories(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.3 Siemens Healthcare(Germany)
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Siemens Healthcare(Germany) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Siemens Healthcare(Germany) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.4 Agilent Technologies Inc(Germany)
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Agilent Technologies Inc(Germany) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Agilent Technologies Inc(Germany) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.5 Illumina Inc.(US)
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Illumina Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Illumina Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.6 Becton Dickinson and Co.(US)
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Becton Dickinson and Co.(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Becton Dickinson and Co.(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.7 QIAGEN N.V.(Germany)
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 QIAGEN N.V.(Germany) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 QIAGEN N.V.(Germany) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.8 Affymetrix Inc.(US)
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Affymetrix Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Affymetrix Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.9 Johnson & Johnson(US)
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Johnson & Johnson(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Johnson & Johnson(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.10 Thermo Fisher Scientific Inc.(US)
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Thermo Fisher Scientific Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Thermo Fisher Scientific Inc.(US) 2016 Next Generation Cancer Diagnostic Devices Business Region Distribution Analysis
    8.11 GE Healthcare(England)
    8.12 Life Technologies Corp.(US)
    8.13 Luminex Corp.(US)
    8.14 Cepheid Inc.(US)
    8.15 Allegro Diagnostics Corp.(Brazil)

9 Development Trend of Analysis of Next Generation Cancer Diagnostic Devices Market
    9.1 Global Next Generation Cancer Diagnostic Devices Market Trend Analysis
        9.1.1 Global 2018-2022 Next Generation Cancer Diagnostic Devices Market Size (Volume and Value) Forecast
        9.1.2 Global 2018-2022 Next Generation Cancer Diagnostic Devices Sales Price Forecast
    9.2 Next Generation Cancer Diagnostic Devices Regional Market Trend
        9.2.1 North America 2018-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
        9.2.2 China 2018-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
        9.2.3 Europe 2018-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
        9.2.4 Southeast Asia 2018-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
        9.2.5 Japan 2018-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
        9.2.6 India 2018-2022 Next Generation Cancer Diagnostic Devices Consumption Forecast
    9.3 Next Generation Cancer Diagnostic Devices Market Trend (Product Type)
    9.4 Next Generation Cancer Diagnostic Devices Market Trend (Application)

10 Next Generation Cancer Diagnostic Devices Marketing Type Analysis
    10.1 Next Generation Cancer Diagnostic Devices Regional Marketing Type Analysis
    10.2 Next Generation Cancer Diagnostic Devices International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Next Generation Cancer Diagnostic Devices by Region
    10.4 Next Generation Cancer Diagnostic Devices Supply Chain Analysis

11 Consumers Analysis of Next Generation Cancer Diagnostic Devices
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Next Generation Cancer Diagnostic Devices Market Professional Survey Report 2018
    Methodology
    Analyst Introduction
    Data Source

Sidebar Menu